Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
出版年份 2022 全文链接
标题
Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
作者
关键词
-
出版物
Journal of Medicinal Chemistry
Volume 65, Issue 21, Pages 14957-14969
出版商
American Chemical Society (ACS)
发表日期
2022-10-27
DOI
10.1021/acs.jmedchem.2c01478
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease
- (2022) Wenli Zhao et al. ACS Chemical Neuroscience
- Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease
- (2022) Renren Bai et al. AGEING RESEARCH REVIEWS
- Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease
- (2022) Johannes Levin et al. Alzheimers & Dementia
- Investigation on the chemical space of the substituted triazole thio-benzoxazepinone RIPK1 inhibitors
- (2022) Yanan Hao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer’s disease
- (2022) Yue Dong et al. Journal of Neuroinflammation
- Structure-based optimizations of a necroptosis inhibitor (SZM594) as novel protective agents of acute lung injury
- (2021) Lijuan Xu et al. CHINESE CHEMICAL LETTERS
- Structure-based bioisosterism design of thio-benzoxazepinones as novel necroptosis inhibitors
- (2021) Chunnian Xia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Necroptosis: A Novel Pathway in Neuroinflammation
- (2021) Ziyu Yu et al. Frontiers in Pharmacology
- Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
- (2021) Charlotte E Teunissen et al. LANCET NEUROLOGY
- Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy
- (2021) Jing Zhu et al. Acta Pharmaceutica Sinica B
- Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model
- (2020) Partow Mirzaee Saffari et al. LIFE SCIENCES
- Apelin attenuates streptozotocin-induced learning and memory impairment by modulating necroptosis signaling pathway
- (2020) Behzad Nasseri et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
- (2020) Yi Sun et al. BIOORGANIC CHEMISTRY
- Inhibitors of RIP1 kinase: a patent review (2016–present)
- (2020) Philip A. Harris EXPERT OPINION ON THERAPEUTIC PATENTS
- Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications
- (2020) Liyuan Cao et al. PHARMACOLOGICAL RESEARCH
- A Multilevel View of the Development of Alzheimer’s Disease
- (2020) Jesús Avila et al. NEUROSCIENCE
- Identification of the Raf kinase inhibitor TAK‐632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3
- (2019) Xiaofei Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure–Activity Relationships, and in Vivo Efficacy
- (2019) Hao Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Melatonin in Alzheimer’s Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer’s Neuropathology
- (2019) Md. Farhad Hossain et al. MOLECULAR NEUROBIOLOGY
- DNL 104, a Centrally Penetrant RIPK 1 Inhibitor, Inhibits RIP 1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers
- (2019) Hendrika W. Grievink et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease
- (2019) Hong Hao Chan et al. Current Alzheimer Research
- Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives
- (2019) Chunlin Zhuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Necroptosis signaling pathways in stroke: from mechanisms to therapies
- (2018) Huang Jun-Long et al. Current Neuropharmacology
- Neuronal Cell Death
- (2018) Michael Fricker et al. PHYSIOLOGICAL REVIEWS
- Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
- (2018) Junying Yuan et al. NATURE REVIEWS NEUROSCIENCE
- Recent Progress in Alzheimer’s Disease Research, Part 1: Pathology
- (2017) Francis T. Hane et al. JOURNAL OF ALZHEIMERS DISEASE
- Necroptosis activation in Alzheimer's disease
- (2017) Antonella Caccamo et al. NATURE NEUROSCIENCE
- RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
- (2017) Dimitry Ofengeim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nec‐1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice
- (2016) Seung‐Hoon Yang et al. EMBO Molecular Medicine
- Programmed necrosis in inflammation: Toward identification of the effector molecules
- (2016) D. Wallach et al. SCIENCE
- The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ
- (2016) Cong Zheng et al. Translational Neurodegeneration
- Necroptosis and its role in inflammation
- (2015) Manolis Pasparakis et al. NATURE
- Necroptosis
- (2014) Andreas Linkermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- The Classification of Microglial Activation Phenotypes on Neurodegeneration and Regeneration in Alzheimer’s Disease Brain
- (2012) Megan M. Varnum et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis
- (2012) Jixi Li et al. CELL
- Microglia and Inflammation in Alzheimers Disease
- (2012) Shweta Mandrekar-Colucci et al. CNS & Neurological Disorders-Drug Targets
- A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats
- (2012) Shivika Rai et al. JOURNAL OF NEUROIMMUNOLOGY
- A Non-transgenic Mouse Model (icv-STZ Mouse) of Alzheimer’s Disease: Similarities to and Differences from the Transgenic Model (3xTg-AD Mouse)
- (2012) Yanxing Chen et al. MOLECULAR NEUROBIOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
- (2009) YoungSik Cho et al. CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started